stockrowEli Lilly and Company (LLY) vs Novartis AG (NVS)
- Eli Lilly and Company LLY 1,370.24 −3.37%
- Novartis AG NVS 162.04 −1.78%
Eli Lilly and Company and Novartis AG are both Drug Manufacturers General companies. Eli Lilly and Company is the larger, with a market value of $1.28T against $296.4B — 4.3× the size. Novartis AG trades at the lower P/E: 30.9× against 44.5×. Eli Lilly and Company grew revenue faster over the last twelve months: 45.5% against 1.76%. Eli Lilly and Company has the higher net margin (31.9% vs 17.5%) and the higher return on invested capital (26.4% vs 12.1%). Both pay a dividend; Novartis AG yields more (2.93% vs 0.49%). Across the 23 metrics below, Eli Lilly and Company leads on 12 and Novartis AG on 11.
Valuation
Profitability
| Metric | LLY | NVS | Drug Manufacturers General median |
|---|---|---|---|
| Gross margin | 83.64% | 74.92% | 73.01% |
| Operating margin | 40.27% | 25.18% | 18.34% |
| Net margin | 31.90% | 17.49% | 7.31% |
| Free cash flow margin | 22.74% | 24.66% | 18.52% |
| Return on equity | 86.02% | 24.37% | 5.80% |
| Return on assets | 20.97% | 8.94% | 2.28% |
| Return on invested capital | 26.42% | 12.05% | 6.26% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack